InsiderTrades

Form 4 for SVV Savers Value Village, Inc.

Accepted 2026-08-07 21:36:41 ET · period of report 2026-08-05 · accession 0001883313-26-000065 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2026-08-07 21:36 2026-08-05+ SVV Medway Richard A. GC M - OptEx $1.94 +55.0K 59.4K +1,239% +$106.7K
DMT 2026-08-07 21:36 2026-08-05+ SVV Medway Richard A. GC S - Sale+OE $11.80 -55.0K 14.4K -79% -$648.9K
DMT 2026-08-07 21:36 2026-08-05+ SVV Medway Richard A. GC M - OptEx $1.94 -55.0K 315.9K -15% -$106.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-05 M A 10,000 $1.41 24,440 D — —
2 Common Common Stock 2026-08-05 S D 10,000 $10.98 14,440 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026.
3 Common Common Stock 2026-08-07 M A 16,656 $3.16 31,096 D — —
4 Common Common Stock 2026-08-07 M A 23,344 $1.41 54,440 D — —
5 Common Common Stock 2026-08-07 M A 5,000 $1.41 59,440 D — —
6 Common Common Stock 2026-08-07 S D 15,000 $11.48 44,440 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026.
7 Common Common Stock 2026-08-07 S D 15,000 $11.98 29,440 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026.
8 Common Common Stock 2026-08-07 S D 15,000 $12.48 14,440 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026.
9 Derivative Stock Options (Right to Purchase) 2026-08-05 M D 10,000 $1.41 23,344 D $1.41 · — to 2029-06-12 10,000 Common Stock (F2) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F3) The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. (F4) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
10 Derivative Stock Options (Right to Purchase) 2026-08-07 M D 16,656 $3.16 87,514 D $3.16 · — to 2030-12-09 16,656 Common Stock (F2) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F5) The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. (F4) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
11 Derivative Stock Options (Right to Purchase) 2026-08-07 M D 23,344 $1.41 0 D $1.41 · — to 2029-06-12 23,344 Common Stock (F2) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F3) The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. (F4) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
12 Derivative Stock Options (Right to Purchase) 2026-08-07 M D 5,000 $1.41 315,912 D $1.41 · — to 2029-06-12 5,000 Common Stock (F2) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F3) The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. (F6) The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately.